TEAM: Immunoproteomic_AMD
Laufzeit: 01.01.2020 - 31.12.2024
imported
Kurzfassung
lmmunoproteomic evaluation of tears and serum in treatment-naive early, intermediate and late age-related macular degeneration (AMD) and neovascular AMD patients
